News Focus
News Focus
icon url

nakedmouse

04/01/07 10:27 AM

#12811 RE: keep_trying #12802

Thank you, KT. What became of Oncolym and Schering trials?

Also note this from 2001 Fool article. Is he gone now?:
>The company has an agreement with a Chinese drug company called Brilliance Pharmaceuticals, which owns the product rights to Cotara in China. This deal was done through a third company called Cancer Therapeutics, to which Peregrine granted an exclusive right to sublicense in China for ten years. But investors should note that this is a related party transaction. According to last year's 10-K filing, Dr. Clive Taylor, who is an officer, director, and 26% owner of Cancer Therapeutics, is also a member of the board of directors of Peregrine Pharmaceuticals. This doesn't necessarily mean it's not a good deal, but I am somewhat skeptical that it will lead to material revenues for Peregrine.<